Vera Therapeutics, Inc.

VERA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$32.23+0.40%

2026-08-03

Financials

Valuation Metrics

Vera Therapeutics, Inc.'s Market Cap is $2.31B. At end of 2025 it was $3.25B. Ranked #1958 of 3,112 in US market (top 63%), #737 of 1,445 on NASDAQ (top 51%), #122 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 45%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.31B	US#1,958/3,112 Sec#122/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-369M	US—/3,112 Sec—/269
Total Assets	$622M	US#2,664/3,112 Sec#135/269
Net Assets	$500M	US#2,263/3,112 Sec#114/269
Value
P/B	4.63x	US#2,103/3,112 Sec#133/269
FCF Yield	-12.70%	US—/3,112 Sec—/269
Profitability
ROE	-73.84%	US#2,816/3,112 Sec#208/269
ROA	-59.34%	US#2,997/3,112 Sec#235/269
Financial Health
Debt Ratio	24.42%	US#263/3,112 Sec#87/269
Total Debt	$75M	US#2,453/3,112 Sec#132/269
FCF	$-294M	US#2,781/3,112 Sec#237/269
Cash	$114M	US#2,140/3,112 Sec#167/269
Current Ratio	13.64x	US#181/3,112 Sec#60/269
Performance
1Y Return	53.84%	US#636/3,112 Sec#111/269
1M Return	-21.77%	US#2,975/3,112 Sec#239/269
From 52W High	-42.50%	US#2,612/3,112 Sec#204/269
1Y MDD	-43.85%	US#2,150/3,112 Sec#161/269
Trading
Volume	1,473,478 shares	US#1,132/3,112 Sec#106/269
Trading Value	$47M	US#1,399/3,112 Sec#90/269
Per Share
EPS	$-4.66	US—/3,112 Sec—/269
BPS	$9.41	US#1,836/3,112 Sec#70/269